May 2003

Sterility Validation and Testing of a Liquid Sampling System logo in a gray background | Sterility Validation and Testing of a Liquid Sampling System
Bioanalytical Methods
Sterility Validation and Testing of a Liquid Sampling SystemSterility Validation and Testing of a Liquid Sampling System
Sterility Validation and Testing of a Liquid Sampling System
May 1, 2003
byBPI Contributor
HACCP: A Process Validation Tool for Ensuring Quality of Biotech and Pharmaceutical Products logo in a gray background | HACCP: A Process Validation Tool for Ensuring Quality of Biotech and Pharmaceutical Products
Bioanalytical Methods
HACCP: A Process Validation Tool for Ensuring Quality of Biotech and Pharmaceutical ProductsHACCP: A Process Validation Tool for Ensuring Quality of Biotech and Pharmaceutical Products
HACCP: A Process Validation Tool for Ensuring Quality of Biotech and Pharmaceutical Products
May 1, 2003
byBPI Contributor
From Discovery to the Clinic logo in a gray background | From Discovery to the Clinic
Process Development
From Discovery to the ClinicFrom Discovery to the Clinic
From Discovery to the Clinic
May 1, 2003
byBPI Contributor
Preventing Hostile Takeovers logo in a gray background | Preventing Hostile Takeovers
Economics
Preventing Hostile TakeoversPreventing Hostile Takeovers
Preventing Hostile Takeovers
May 1, 2003
byBPI Contributor
Products, Services, and Literature logo in a gray background | Products, Services, and Literature
Business
Products, Services, and Literature May 2003Products, Services, and Literature May 2003
Products, Services, and Literature
May 1, 2003
byBPI Contributor
Perspective on the US Position on Comparability and Its Implications for Generic Biotech Products logo in a gray background | Perspective on the US Position on Comparability and Its Implications for Generic Biotech Products
Biosimilars
Perspective on the US Position on Comparability and Its Implications for Generic Biotech ProductsPerspective on the US Position on Comparability and Its Implications for Generic Biotech Products
Perspective on the US Position on Comparability and Its Implications for Generic Biotech Products
May 1, 2003
byBPI Contributor
On Problem Investigations (Part 2) logo in a gray background | On Problem Investigations (Part 2)
Regulatory Affairs
On Problem Investigations (Part 2)On Problem Investigations (Part 2)
On Problem Investigations (Part 2)
May 1, 2003
byBPI Contributor
First Amendment Protection of Commercial Speech logo in a gray background | First Amendment Protection of Commercial Speech
Business
First Amendment Protection of Commercial SpeechFirst Amendment Protection of Commercial Speech
First Amendment Protection of Commercial Speech
May 1, 2003
byBPI Contributor
Get Noticed — for the Right Reasons logo in a gray background | Get Noticed — for the Right Reasons
Business
Get Noticed — for the Right ReasonsGet Noticed — for the Right Reasons
Get Noticed — for the Right Reasons
May 1, 2003
byBPI Contributor
Diafiltration for Desalting or Buffer Exchange logo in a gray background | Diafiltration for Desalting or Buffer Exchange
Biochemicals/Raw Materials
Diafiltration for Desalting or Buffer ExchangeDiafiltration for Desalting or Buffer Exchange
Diafiltration for Desalting or Buffer Exchange
May 1, 2003
byBPI Contributor

Webinars

Ask the Expert webcasts
ATE Webcasts
Register Now: Evaluation of a New Multimodal Anion Exchange Resin for Emerging Biotherapeutic Process Challenges
Register Now: Evaluation of a New Multimodal Anion Exchange Resin for Emerging Biotherapeutic Process Challenges
Ask the Expert webcasts
ATE Webcasts
Register Now: Linking mAb Product Quality Profile Changes to Your Bioprocess: Case Study of Dynamic Glucose Level Control in CHO Process Improves Product Quality
Register Now: Linking mAb Product Quality Profile Changes to Your Bioprocess: Case Study of Dynamic Glucose Level Control in CHO Process Improves Product Quality
Ask the Expert webcasts
ATE Webcasts
Register Now: Navigating Biopharma Commercialization: The Interplay of Regulatory Affairs, Process Development, and Manufacturing to Ensure Drug Quality
Register Now: Navigating Biopharma Commercialization: The Interplay of Regulatory Affairs, Process Development, and Manufacturing to Ensure Drug Quality
Insider News
See all
Dec 2 - Dec 5, 2024
The European Cell and Gene Therapy Congress for Groundbreaking Manufacturing, Commercialisation & Analytical Strategies: World renowned leaders share the latest process development, analytical and market access strategies to improve manufacturing scalability, quality and cost to propel your CGT programmes to commercial success
Learn More

Innovative Technology

Emerson white paper
Sponsored Content
Sustainability in Life Sciences: Actionable Solutions for Improving Energy Efficiency
Sustainability in Life Sciences: Actionable Solutions for Improving Energy Efficiency

Nov 12, 2024

WuXi Bio white paper
Sponsored Content
Empowering Modern Drug Product Development: Breakthroughs in High-Concentration Formulations and Drug-Device Combination Products
Empowering Modern Drug Product Development: Breakthroughs in High-Concentration Formulations and Drug-Device Combination Products

Nov 8, 2024

Bora white paper
Sponsored Content
Redefining Scalability: Strategies for Enhancing Early Drug Development to Future-Proof Later Stages
Redefining Scalability: Strategies for Enhancing Early Drug Development to Future-Proof Later Stages

Nov 8, 2024